Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?

Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?

FromKeeping Current CME


Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?

FromKeeping Current CME

ratings:
Length:
21 minutes
Released:
Jan 17, 2024
Format:
Podcast episode

Description

Expert insights on the latest clinical findings on targeting Bruton tyrosine kinase (BTK) and B-cell lymphoma 2 (Bcl-2) to treat B-cell malignancies. Credit available for this activity expires: 1/12/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999658?ecd=bdc_podcast_libsyn_mscpedu
Released:
Jan 17, 2024
Format:
Podcast episode

Titles in the series (100)

Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.